期刊文献+

藿蓉补肾颗粒与吲哚美辛片治疗少弱精子症的临床疗效对比 被引量:13

Comparison of Clinical Efficacy between Huorongbushen and Indomethacin in Patients with Oligospermia or Asthenospermia
在线阅读 下载PDF
导出
摘要 目的:比较应用藿蓉补肾颗粒与吲哚美辛片治疗少弱精子症的临床疗效。方法:男性不育门诊中少弱精子症患者86例,随机分为A、B两组,每组43例,A组服用藿蓉补肾颗粒16 g/次,3次/d,B组服用吲哚美辛片25mg/次,2次/d,连用3个月。分别于治疗前及治疗3个月后行计算机辅助精液分析,比较每组治疗前后精子密度、前向精子活动率、总活动率、直线运动速率、平均运动速率等精液参数。结果:A组各项精液观察指标治疗前后差异均有显著性(P<0.05),B组除精子密度外其他精液观察参数指标治疗后较治疗前改善有显著性差异(P<0.05)。两组间比较精子密度A组比B组改善差异显著(P<0.05),其他观察参数改善在A、B两组间无显著性差异(P>0.05)。结论:藿蓉补肾颗粒治疗少弱精子症疗效明显,且不良反应轻微。 Objective : To compare the clinical efficacy and safety between Huorongbushen and indomethacin in patients with oligospermia or asthenospermia. Methods : 86 patients with oligoasthenospermia were received at our clinic of andrology. They were randomly divided into group A and B. The patients in group A received Huorongbushen 48 g daily for 3 months, and the other patients in group B were given indomethacin 50 mg daily for 3 months. The sperm parameters of the patients were analyzed by computer-assisted sperm analysis system before and after treatment. Results : Patients of group A were significantly improved in sperm concentration, forward sperm motility, total sperm motility, straight line velocity and average path velocity. Patients of group B remained unimproved in sperm concentration and were significantly improved in other sperm parameters. The patients in group A reported a significantly higher sperm concentration than that in group B. There was no significant difference between group A and B in other sperm parameters. Conclusion: Compared with indomethacin, Huorongbushen is efficacious for oligoasthenospermia with lower side effects.
出处 《中华男科学杂志》 CAS CSCD 2005年第8期621-623,共3页 National Journal of Andrology
关键词 少弱精子症 藿蓉补肾颗粒 吲哚美辛片 oligospermia, asthenospermia Huorongbushen indomethacin
  • 相关文献

参考文献12

二级参考文献135

共引文献529

同被引文献226

引证文献13

二级引证文献170

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部